Financial Summary (All financials)
| In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
| Revenues | 4,538.8 | 5,481.1 | 5,252.3 | 2,975.9 | 2,788.3 | 2,566.9 | 2,221.4 | 2,018.1 |
| Revenue growth | -17.2% | 4.4% | 76.5% | 6.7% | 8.6% | 15.6% | 10.1% | 0.7% |
| Cost of goods sold | 2,806.4 | 3,204.1 | 2,903.2 | 1,838.7 | 1,738.0 | 1,648.7 | 1,395.2 | 1,337.1 |
| Gross profit | 1,732.4 | 2,277.0 | 2,349.1 | 1,137.2 | 1,050.4 | 918.1 | 826.2 | 681.0 |
| Gross margin | 38.2% | 41.5% | 44.7% | 38.2% | 37.7% | 35.8% | 37.2% | 33.7% |
| Sales and marketing | 809.2 | 1,025.9 | 770.3 | 533.3 | 488.3 | 435.5 | 379.6 | 319.0 |
| Research and development | 280.8 | 291.8 | 226.0 | 177.6 | 161.2 | 143.8 | 130.5 | 113.6 |
| General and administrative | 124.7 | 148.6 | 166.6 | 94.0 | 98.7 | 96.4 | 100.3 | 101.5 |
| EBITA | 517.4 | 806.3 | 1,185.6 | 330.7 | 298.7 | 245.2 | 221.3 | 148.7 |
| EBITA margin | 11.4% | 14.7% | 22.6% | 11.1% | 10.7% | 9.6% | 10.0% | 7.4% |
| Amortization of intangibles | 24.4 | 30.2 | 31.8 | 30.9 | 24.2 | 15.6 | 9.4 | 1.9 |
| EBIT | 493.0 | 776.2 | 1,153.8 | 299.9 | 274.5 | 229.6 | 211.9 | 146.9 |
| EBIT margin | 10.9% | 14.2% | 22.0% | 10.1% | 9.8% | 8.9% | 9.5% | 7.3% |
| Pre-tax income | 463.5 | 775.8 | 1,148.1 | 324.3 | 271.1 | 232.3 | 215.0 | 131.5 |
| Income taxes | 98.9 | 131.3 | 200.9 | -125.4 | 13.6 | 23.7 | 9.1 | 3.1 |
| Tax rate | 21.3% | 16.9% | 17.5% | | 5.0% | 10.2% | 4.2% | 2.4% |
| Earnings from continuing ops | 364.6 | 644.5 | 947.3 | 449.7 | 257.6 | 208.5 | 205.9 | 128.4 |
| Earnings from discontinued ops | | | | | | | | -9.0 |
| Net income | 364.6 | 644.5 | 947.3 | 449.7 | 257.6 | 208.5 | 205.9 | 119.3 |
| Net margin | 8.0% | 11.8% | 18.0% | 15.1% | 9.2% | 8.1% | 9.3% | 5.9% |
| |
| Diluted EPS | $2.23 | $3.78 | $5.51 | $2.66 | $1.52 | $1.23 | $1.24 | $0.77 |
| Shares outstanding (diluted) | 163.7 | 170.4 | 171.8 | 169.4 | 169.0 | 169.0 | 165.5 | 165.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|